NASDAQ:REPL

Replimune Group Stock Forecast

etoro logo Buy REPL
*Your capital is at risk
$8.77
-0.220 (-2.45%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of REPL
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Replimune Group Inc. stock price ended at $8.77 on Monday, after losing 2.45%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 22, 2025 Gain 5.66%

The Replimune Group Inc. stock price fell by -2.45% on the last day (Monday, 17th Nov 2025) from $8.99 to $8.77. During the last trading day the stock fluctuated 6.47% from a day low at $8.74 to a day high of $9.30. The price has fallen in 7 of the last 10 days and is down by -5.75% for this period. Volume has increased on the last day by 155 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $15.88 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 64.22% during the next 3 months and, with a 90% probability hold a price between $9.80 and $18.77 at the end of this 3-month period.

REPL Signals & Forecast

A sell signal was issued from a pivot top point on Tuesday, October 28, 2025, and so far it has fallen -16.08%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Replimune Group Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $8.85. On a fall, the stock will find some support from the long-term average at approximately $7.24. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Replimune Group Inc. stock

Replimune Group Inc. finds support from accumulated volume at $8.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.565 between high and low, or 6.47%. For the last week, the stock has had daily average volatility of 8.17%.

Our recommended stop-loss: $8.29 (-5.43%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (REPL) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Replimune Group Inc. to open at $8.94, and during the day (based on 14 day Average True Range), to move between $8.41 and $9.13, which gives a possible trading interval of +/-$0.720 (+/-8.56%) up or down from last closing price. If Replimune Group Inc. takes out the full calculated possible swing range there will be an estimated 8.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.95 (2.00%) than the support at $8.42 (3.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Replimune Group Inc. stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 2.318 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $8.94 ( 1.88%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

REPL Performance

Trading levels for REPL

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.50 8.32%
R2 9.28 5.86%
R1 9.15 4.34%
Price 8.77
S1 8.72 -0.580%
S2 8.59 -2.10%
S3 8.37 -4.56%

Accumulated Volume Support & Resistance Levels

Level Price
R3 10.45 19.16%
R2 9.31 6.10%
R1 8.95 2.00%
Price 8.77
S1 8.42 -3.99%
S2 8.30 -5.36%
S3 8.10 -7.64%

FAQ

What is the symbol for Replimune Group Inc. Stock and on which exchange is it traded?
The symbol for Replimune Group Inc. is REPL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Replimune Group Inc. Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy Replimune Group Inc. Stock?
Replimune Group Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Replimune Group Inc. Stock.

What's the current price of Replimune Group Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Replimune Group Inc. (REPL) share was $8.77.

What is the 52-week high and low for Replimune Group Inc. Stock?
The 52-week high for Replimune Group Inc. Stock is $17.00 and the 52-week low is $2.68.

What is the market capitalization of Replimune Group Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Replimune Group Inc. is 687.92M.

When is the next earnings date for Replimune Group Inc.?
The upcoming earnings date for Replimune Group Inc. is Feb 11, 2026.
Click to get the best stock tips daily for free!
ABOUT REPLIMUNE GROUP INC.
Replimune Group
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE